Enovis Appoints Damien McDonald CEO, Reaffirms Q1 Guidance Amid Strategic Growth Push

Enovis has named veteran medtech leader Damien McDonald as its new CEO effective 12 May as the orthopedic company reaffirms first-quarter 2025 revenue guidance of between $555m and $563m. Medtech Insight spoke with Tim Czartoski, Enovis’ president of US surgical and global product and enabling technologies, about the firm’s growth strategy and innovation plans.

Altivate Reverse shoulder implant
(Enovis)

Enovis recently announced the appointment of medtech veteran Damien McDonald as its new CEO and confirmed financial guidance for the first quarter, projecting revenues between $555m and $563m.

Tim Czartoski, president of US surgical and global product and enabling technologies at Enovis, one of the largest orthopedic companies worldwide, expressed excitement about the appointment of McDonald. McDonald will...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Orthopedics

More from Medtech Insight